Skip to main content
Livermore
Livermore
ZHEN

Hall Private Wealth Advisors

SEC CIK
0001744091
Latest filing
Nov 15, 2023

The latest 13F from Hall Private Wealth Advisors covers Q3 2023 (filed Nov 15, 2023): 39 long positions worth $148.8M. The top 10 holdings make up 71.7% of the portfolio, and the largest is Apple Inc. (AAPL) at 12.0%. Livermore has 10 filings on Form 13F from this institution, going back to Q2 2021.

What changed in Q3 2023

Share counts compared with Q2 2023: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
2
Est. +$402.3K
Added
12
Est. +$8.16M
Reduced
22
Est. −$19.3M
Sold out
9
Est. −$13.8M

Top 5 holdings

Share of this quarter's portfolio value

  1. AAPLApple Inc.
    12.0%$17.8MHistory
  2. State Street SPDR Bloomberg Convertible Securities ETF78464A359
    11.8%$17.5M
  3. DLRDigital Realty Trust, Inc.
    8.5%$12.6MHistory
  4. Vanguard Information Technology ETF92204A702
    7.1%$10.5M
  5. AMZNAmazon Com Inc
    7.0%$10.5MHistory

Biggest buys

New and added positions, by estimated amount bought

  1. AAPLApple Inc.
    +$4.28MAddedHistory
  2. Vanguard Morningstar Value ETF922908744
    +$705.2KAdded
  3. NACNuveen California Quality Municipal Income Fund
    +$696.1KAddedHistory
  4. COSTCostco Wholesale Corp
    +$487.6KAddedHistory
  5. Invesco QQQ Trust Series I46090E103
    +$467.2KAdded

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. AAPLApple Inc.
    +3.69 pp8.3% → 12.0%History
  2. State Street SPDR Bloomberg Convertible Securities ETF78464A359
    +2.25 pp9.5% → 11.8%
  3. DLRDigital Realty Trust, Inc.
    +2.12 pp6.4% → 8.5%History
  4. COSTCostco Wholesale Corp
    +1.72 pp4.6% → 6.3%History
  5. AMZNAmazon Com Inc
    +1.29 pp5.7% → 7.0%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. ATVIActivision Blizzard, Inc.
    −$10.4MSold outHistory
  2. iShares U.S. Medical Devices ETF464288810
    −$3.93MReduced
  3. XIFRXPLR Infrastructure, LP
    −$3.18MReducedHistory
  4. IRMIron Mountain Inc
    −$2.93MReducedHistory
  5. DDominion Energy, Inc
    −$2.21MSold outHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. ATVIActivision Blizzard, Inc.
    −5.60 pp5.6% → 0.0%History
  2. XIFRXPLR Infrastructure, LP
    −3.79 pp4.5% → 0.7%History
  3. iShares U.S. Medical Devices ETF464288810
    −2.24 pp5.9% → 3.6%
  4. DDominion Energy, Inc
    −1.19 pp1.2% → 0.0%History
  5. MDTMedtronic plc
    −0.88 pp2.2% → 1.4%History

Metrics

13F metrics for Q3 2023, computed only from the numbers in the filings. Definitions below.

Portfolio value
$148.8M
−$36.2M (−19.6%) vs. prior quarter
Positions
39
−7 vs. prior quarter
Top 10 concentration
71.7%
Top 10 as share of value
Turnover
5.1%
Q3 2023, one quarter
Average holding period
8.3 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q2 2021), so positions held before then are understated.

13F filings by quarter

10 quarters, going back to Q2 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $192.0M (Q1 2023)

Q2 2021: $153.6MQ3 2021: $156.8MQ4 2021: $161.0MQ1 2022: $187.3MQ2 2022: $178.2MQ3 2022: $173.7MQ4 2022: $175.9MQ1 2023: $192.0MQ2 2023: $185.0MQ3 2023: $148.8M
Q2 2021Q3 2023
13F filings of Hall Private Wealth Advisors by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q3 2023Nov 15, 202339$148.8MAAPLState Street SPDR Bloomberg Convertible Securities ETFDLRvs. Q2 2023SEC
Q2 2023Jul 17, 202346$185.0MState Street SPDR Bloomberg Convertible Securities ETFAAPLDLRvs. Q1 2023SEC
Q1 2023Apr 18, 202352$192.0MState Street SPDR Bloomberg Convertible Securities ETFAAPLiShares U.S. Medical Devices ETFvs. Q4 2022SEC
Q4 2022Jan 23, 202348$175.9MState Street SPDR Bloomberg Convertible Securities ETFIRMGILDvs. Q3 2022SEC
Q3 2022Oct 31, 202240$173.7MState Street SPDR Bloomberg Convertible Securities ETFAAPLIRMvs. Q2 2022SEC
Q2 2022Jul 20, 202241$178.2MState Street SPDR Bloomberg Convertible Securities ETFIRMiShares U.S. Medical Devices ETFvs. Q1 2022SEC
Q1 2022May 2, 202250$187.3MIRMState Street SPDR Bloomberg Convertible Securities ETFiShares U.S. Medical Devices ETFvs. Q4 2021SEC
Q4 2021Jan 28, 202246$161.0MiShares U.S. Medical Devices ETFIRMState Street SPDR Bloomberg Convertible Securities ETFvs. Q3 2021SEC
Q3 2021Nov 12, 202151$156.8MiShares U.S. Medical Devices ETFState Street SPDR Bloomberg Convertible Securities ETFIRMvs. Q2 2021SEC
Q2 2021Aug 16, 202152$153.6MIRMState Street SPDR Bloomberg Convertible Securities ETFiShares U.S. Medical Devices ETF–SEC